Who owns NEUROPACE INC?
- Ticker: NPCE
- CUSIP Number: 641288105
Tip: Access positions for across all investors
Analyze quarterly positions in Neuropace with up to 7 years of data, all consolidated into one spreadsheet
Download as csv Download as ExcelTop investors of Neuropace stock
Who bought or sold NEUROPACE INC this quarter?
Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
---|---|---|---|---|---|
KCK | 5.6M | $55M | 0% | Sep 2023 |
|
OrbiMed Advisors | 4.0M | $41M | 0% | Dec 2023 |
|
Soleus Capital Management | 2.4M | $25M | -1% | Dec 2023 |
|
Morgan Stanley | 2.4M | $23M | 2% | Sep 2023 |
|
Nantahala Capital Management | 1.2M | $12M | -4% | Dec 2023 |
|
FMR | 706k | $6.9M | -42% | Sep 2023 |
|
Kent Lake Capital | 671k | $6.9M | 17% | Dec 2023 |
|
Vanguard Group | 413k | $4.3M | 7% | Dec 2023 |
|
Millennium Management | 172k | $1.8M | -6% | Dec 2023 |
|
Eudaimonia Asset Management | 142k | $1.4M | 100% | Sep 2023 |
|
Geode Capital Management | 110k | $1.1M | 54% | Sep 2023 |
|
Bridgeway Capital Management | 60k | $584k | 0% | Sep 2023 |
|
BlackRock | 60k | $584k | 66% | Sep 2023 |
|
Renaissance Technologies | 44k | $431k | 156% | Sep 2023 |
|
Jane Street | 37k | $380k | 100% | Dec 2023 |
|
Citigroup | 35k | $361k | 1074% | Dec 2023 |
|
State Street Corporation | 33k | $324k | 48% | Sep 2023 |
|
Bank of America Corporation | 32k | $329k | 480% | Dec 2023 |
|
Balyasny Asset Management | 27k | $280k | 100% | Dec 2023 |
|
683 Capital Management | 25k | $257k | 100% | Dec 2023 |
|
Citadel Advisors | 24k | $248k | 100% | Dec 2023 |
|
Northern Trust | 22k | $216k | 38% | Sep 2023 |
|
Laurion Capital Management | 21k | $213k | 100% | Dec 2023 |
|
Man Group | 19k | $199k | 100% | Dec 2023 |
|
Townsquare Capital | 16k | $164k | 100% | Dec 2023 |
|
Walleye Trading Advisors | 14k | $148k | 100% | Dec 2023 |
|
Marshall Wace | 14k | $146k | 100% | Dec 2023 |
|
Barclays | 14k | $147k | 29% | Dec 2023 |
|
Cubist Systematic Strategies | 11k | $118k | 100% | Dec 2023 |
|
Jpmorgan Chase & Co | 11k | $117k | 100% | Dec 2023 |
|
Virtu Financial | 11k | $111k | 100% | Dec 2023 |
|
Financial Advocates Investment Management | 10k | $103k | 0% | Dec 2023 |
|
Lazard Asset Management | 3.9k | $40k | 100% | Dec 2023 |
|
Qube Research & Technologies | 2.4k | $23k | 100% | Sep 2023 |
|
Point72 Asia | 257.00 | $2.7k | 100% | Dec 2023 |
|
Advisor Group Holdings | 233.00 | $2.4k | 100% | Dec 2023 |
|
Royal Bank of Canada | 118.00 | $1.0k | 2850% | Dec 2023 |
|
Federated Investors | 116.00 | $1.2k | -73% | Dec 2023 |
|
Wells Fargo & Company | 81.00 | $834.996600 | 9% | Dec 2023 |
|
Who sold out of Neuropace?
Fund or Company Name | Date Sold | Shares Held | Valued At |
---|---|---|---|
Tower Research Capital | Jun 2023 | 90.00 | $404.001000 |